Upcoming earnings put Anheuser-Busch InBev in focus
Anheuser-Busch InBev (ENXTBR:ABI) moves into the spotlight as the brewer heads toward its third quarter 2026 earnings release on October 29, with Wall Street watching revenue and profit expectations closely.
Over the past year, Anheuser-Busch InBev has shifted from short-term pullbacks to stronger momentum, with a 30 day share price return of 8.75% and a year to date share price gain of 35.29%, feeding into a 1 year total shareholder return of 40.91% that points to investors reassessing both growth prospects and risk.
Scan other consumer-focused stocks showing similar earnings momentum and re-rating potential to Anheuser-Busch InBev using our curated list of 195 high quality undervalued stocks .
Bulls see Anheuser-Busch InBev's recent 1 year run and earnings optimism as proof the rerating has further to go. Bears see stretched expectations instead. Which story do the current valuation markers support?
Most Popular Narrative: 18% Undervalued
Anheuser-Busch InBev last closed at €73.60, while the most followed narrative on the stock pegs fair value at €89.45, creating a clear gap that current pricing has not closed yet and putting fresh attention on what is driving that estimate.
ABI is transitioning into:
a premiumized portfolio
a more efficient operating system
a deleveraged balance sheet
In other words:
ABI is becoming a cash flow machine with improving quality.
If execution continues, valuation expansion + margin expansion + dividends create a triple compounding effect.
See why 16 investors see Anheuser-Busch InBev as 18% undervalued .
Result: Fair Value of €89.45 (UNDERVALUED)
Still, the Anheuser-Busch InBev story can break if premiumisation or margin goals stall, or if any renewed hit to cash flow slows debt reduction.
Find out about the key risks to this Anheuser-Busch InBev narrative .
Next Steps
If the Anheuser-Busch InBev story so far feels finely balanced between optimism and concern, now is the moment to test the numbers yourself and decide how you see the trade off between risks and potential upside. To weigh both sides in one place, start with the 4 key rewards and 1 important warning sign .
Looking for more Anheuser-Busch InBev investment ideas?
Do not stop your research with Anheuser-Busch InBev. Broaden your watchlist using focused screeners that surface clear themes and help you act before the crowd moves.
-
Hunt for underappreciated quality by scanning a curated 195 high quality undervalued stocks that combine robust fundamentals with prices that still lag underlying business strength.
-
Strengthen your defensive side by reviewing a 223 resilient stocks with low risk scores built to spotlight resilient businesses with lower risk profiles.
-
Get ahead of the crowd by filtering for a 610 high quality undiscovered gems that highlight lesser known companies with solid financial underpinnings.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ABI.BR .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
